Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för bendazac. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

10 träffar

Bibliografisk träff 1995-12-01

Radical scavenger activity of bendazac, an anticataract non-steroidal anti-inflammatory agent.

Guglielmotti A, Capezzone De Joannon A, Cazzolla N, Marchetti M, Soldo L, Cavallo G, Pinza M.

Pharmacol Res · journal article · DOI 10.1016/s1043-6618(05)80042-8

Bibliografisk träff 1993-03-01

Clinical study of bendazac lysine for in vivo contact lens cleaning.

Evans TC, Levy B, Szabocsik J.

Optom Vis Sci · research support, non-u.s. gov't; journal article · DOI 10.1097/00006324-199303000-00007

Bibliografisk träff 1991-12-01

Validation of a HPLC method for the determination of bendazac and its main metabolite 5-hydroxybendazac in rabbit aqueous humor and its applicability to human aqueous.

Catanese B, Picollo R, Panei M, Martinelli B, Durando L, Baravelli S.

Boll Chim Farm · journal article

Bibliografisk träff 1990-04-01

Bendazac lysine. A review of its pharmacological properties and therapeutic potential in the management of cataracts.

Balfour JA, Clissold SP.

Drugs · review; journal article · DOI 10.2165/00003495-199039040-00007

Bibliografisk träff 1988-01-01

Development of separation fluoroimmunoassays for bendazac and 5-hydroxy bendazac.

Staley K, Coxon R, Gallacher G, Landon J.

Ther Drug Monit · journal article · DOI 10.1097/00007691-198803000-00015

Bibliografisk träff 1987-01-01

The neutralization of hydroxyl radical by silibin, sorbinil and bendazac.

Mira ML, Azevedo MS, Manso C.

Free Radic Res Commun · comparative study; journal article · DOI 10.3109/10715768709088097

Bibliografisk träff 1986-12-01

Bendazac prevents cyanate binding to soluble lens proteins and cyanate-induced phase-separation opacities in vitro: a possible mechanism by which bendazac could delay cataract.

Lewis BS, Rixon KC, Harding JJ.

Exp Eye Res · research support, non-u.s. gov't; journal article · DOI 10.1016/0014-4835(86)90075-8

Bibliografisk träff 1970-01-01

Clinical evaluation of bendazac (AF-983). A non-steroid topical anti-inflammatory agent.

De Gregorio M, Meneghelli PL.

Acta Derm Venereol · controlled clinical trial; comparative study; clinical trial; randomized controlled trial; journal article · DOI 102340/0001555550466468

Bibliografisk träff 1969-01-01

Pharmacological properties of bendazac (AF 983) with particular reference to its topical action on some experimental inflammatory processes.

Silvestrini B, Cioli V, Burberi S.

Arzneimittelforschung · journal article

Bibliografisk träff 1968-10-01

[Clinical evaluation of a new topical anti-inflammatory agent: bendazolic acid (bendazac)].

Zar E, De Gregorio M.

Arch Chir Torac Cardiovasc · journal article